Delivery Order SPE2DB20D1047-SPE2DB25FF72B
- Not listed
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Armodafinil 250 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $2,910.87. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,075.08 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count packages). This non-competitive, firm fixed-price delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and this...
- The Defense Logistics Agency has awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units). This competitive, firm fixed-price delivery order was executed on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $1,196.97. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) with a ceiling value of $2,024.58. This non-set-aside, competitively awarded contract employs firm fixed price pricing and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same area. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF72BDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,927.46 by the Defense Logistics Agency on July 15, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award through open procurement. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The Defense Logistics Agency utilizes the DLA Troop Support Medical indefinite delivery vehicle to supply a broad range of pharmaceutical products and medical commodities to support Department of Defense healthcare requirements. AmerisourceBergen's established presence as a prime vendor under this contract vehicle demonstrates its capability to meet federal procurement standards for critical pharmaceutical supplies. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of July 16, 2025, reflecting the expedited nature of this individual delivery order within the broader DLA medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/15/25 |